antifungal therapy (combination, step-down, salvage)
TRANSCRIPT
![Page 1: Antifungal therapy (combination, step-down, salvage)](https://reader033.vdocuments.us/reader033/viewer/2022041609/6252f17f1b829c568d444145/html5/thumbnails/1.jpg)
Antifungal therapy (combination, step-down, salvage)
Hossein Khalili, Pharmacotherpy, TUMS
![Page 2: Antifungal therapy (combination, step-down, salvage)](https://reader033.vdocuments.us/reader033/viewer/2022041609/6252f17f1b829c568d444145/html5/thumbnails/2.jpg)
Combination therapy (advantages)
• Additive or synergic effects
• Resistant fungi
• Coverage
• Dose reduction
![Page 3: Antifungal therapy (combination, step-down, salvage)](https://reader033.vdocuments.us/reader033/viewer/2022041609/6252f17f1b829c568d444145/html5/thumbnails/3.jpg)
Combination therapy (disadvantages)
• Antagonism
• Interactions
• Toxicity
• Cost
![Page 4: Antifungal therapy (combination, step-down, salvage)](https://reader033.vdocuments.us/reader033/viewer/2022041609/6252f17f1b829c568d444145/html5/thumbnails/4.jpg)
Evidence
![Page 5: Antifungal therapy (combination, step-down, salvage)](https://reader033.vdocuments.us/reader033/viewer/2022041609/6252f17f1b829c568d444145/html5/thumbnails/5.jpg)
Evidence
![Page 6: Antifungal therapy (combination, step-down, salvage)](https://reader033.vdocuments.us/reader033/viewer/2022041609/6252f17f1b829c568d444145/html5/thumbnails/6.jpg)
What need to know before selecting an antifungal agent?
Molecular characteristics and structure-related activity
![Page 7: Antifungal therapy (combination, step-down, salvage)](https://reader033.vdocuments.us/reader033/viewer/2022041609/6252f17f1b829c568d444145/html5/thumbnails/7.jpg)
Triazole antifungals molecular characteristics
Drug Molecular
weight
Polarity lipophilicity Permeability Protein
binding
Vd T1/2(h)
Itraconazole 705 101 4.89 1.85 99.8% 11 34-42
Posaconazole 700 112 4.41 1.94 >98 7-
25
29
Isavuconazole 437 88 3.62 4.03 >99 6 110
Voriconazole 349 76 2.13 4.5 58 4.6 6
Fluconazole 306 81 0.82 4.06 12 0.7 30
![Page 8: Antifungal therapy (combination, step-down, salvage)](https://reader033.vdocuments.us/reader033/viewer/2022041609/6252f17f1b829c568d444145/html5/thumbnails/8.jpg)
Azole’ chemical structure
![Page 9: Antifungal therapy (combination, step-down, salvage)](https://reader033.vdocuments.us/reader033/viewer/2022041609/6252f17f1b829c568d444145/html5/thumbnails/9.jpg)
![Page 10: Antifungal therapy (combination, step-down, salvage)](https://reader033.vdocuments.us/reader033/viewer/2022041609/6252f17f1b829c568d444145/html5/thumbnails/10.jpg)
![Page 11: Antifungal therapy (combination, step-down, salvage)](https://reader033.vdocuments.us/reader033/viewer/2022041609/6252f17f1b829c568d444145/html5/thumbnails/11.jpg)
![Page 12: Antifungal therapy (combination, step-down, salvage)](https://reader033.vdocuments.us/reader033/viewer/2022041609/6252f17f1b829c568d444145/html5/thumbnails/12.jpg)
Interactions between antifungals depend on: • Type of drug (itraconazole vs. voriconazole)
• Antifungal half-life
• Administration interval (at least 12 hours)
• Type of fungus (crypotococcus vs. aspegillosis)
• Fungus structure (ergosterol or lanosterol content)
![Page 13: Antifungal therapy (combination, step-down, salvage)](https://reader033.vdocuments.us/reader033/viewer/2022041609/6252f17f1b829c568d444145/html5/thumbnails/13.jpg)
Step-down therapy
• De-escalation
![Page 14: Antifungal therapy (combination, step-down, salvage)](https://reader033.vdocuments.us/reader033/viewer/2022041609/6252f17f1b829c568d444145/html5/thumbnails/14.jpg)
Salvage therapy
• Refractory
• Progressive
![Page 15: Antifungal therapy (combination, step-down, salvage)](https://reader033.vdocuments.us/reader033/viewer/2022041609/6252f17f1b829c568d444145/html5/thumbnails/15.jpg)
Invasive Aspergillosis
Salvage therapy Step-down therapy Combination therapy Initial therapy
-Voriconazole
+Echinocandin
-Liposomal amphotericin B+
Echinocandin
Voriconazole Voriconazole +
Echinocandin
-Voriconazole
-Posaconazole
-Isavoconazole
10 to 14 days combination
therapy then step-down to
Voriconazole
6 to 12 weeks (minimum) Duration
![Page 16: Antifungal therapy (combination, step-down, salvage)](https://reader033.vdocuments.us/reader033/viewer/2022041609/6252f17f1b829c568d444145/html5/thumbnails/16.jpg)
Azole choice:
• Organ dysfunction
• Toxicities
• Tolerability
• Need for initial intravenous therapy
![Page 17: Antifungal therapy (combination, step-down, salvage)](https://reader033.vdocuments.us/reader033/viewer/2022041609/6252f17f1b829c568d444145/html5/thumbnails/17.jpg)
Azole choice:
• Posaconazole and isavuconazole are the preferred alternatives for patients who cannot tolerate voriconazole
• Both have been shown to be as effective as voriconazole and
• However, clinical experience with these agents is limited
![Page 18: Antifungal therapy (combination, step-down, salvage)](https://reader033.vdocuments.us/reader033/viewer/2022041609/6252f17f1b829c568d444145/html5/thumbnails/18.jpg)
Posaconazole over voriconazole
• In patients who have sustained visual disturbances, other neurologic disturbances, or dermatologic toxicity with voriconazole
![Page 19: Antifungal therapy (combination, step-down, salvage)](https://reader033.vdocuments.us/reader033/viewer/2022041609/6252f17f1b829c568d444145/html5/thumbnails/19.jpg)
Isavuconazole over voriconazole
• In patients with a prolonged QTc
• Patients who require intravenous therapy but cannot receive intravenous voriconazole due to its cyclodextrin vehicle
![Page 20: Antifungal therapy (combination, step-down, salvage)](https://reader033.vdocuments.us/reader033/viewer/2022041609/6252f17f1b829c568d444145/html5/thumbnails/20.jpg)
Amphotericin B over azoles
• Patients with severe hepatotoxicity
• There is a concern for drug interactions with azoles
![Page 21: Antifungal therapy (combination, step-down, salvage)](https://reader033.vdocuments.us/reader033/viewer/2022041609/6252f17f1b829c568d444145/html5/thumbnails/21.jpg)
Resistance?
• Mucorales are intrinsically resistant to voriconazole
• A.terreus has high MICs to amphotericin B
• Combination therapy
![Page 22: Antifungal therapy (combination, step-down, salvage)](https://reader033.vdocuments.us/reader033/viewer/2022041609/6252f17f1b829c568d444145/html5/thumbnails/22.jpg)
Salvage therapy Step-down therapy Combination therapy Initial therapy
-Echinocandin
-Flucytosine
-Voriconazole
-High-dose Fluconazole
(C.glabrta)
-Voriconazole
-Amphotericin
B+Flucytosin
-Posaconazole
+Caspofungin
-Amphotericin B+
Fluconazole
-Echinocandin
-Azoles
5 to 7 days after inanition B/C
negative
Fluconazole (oral)
Continue treatment for 14
days after negative B/C
culture
Duration
Invasive candidiasis
![Page 23: Antifungal therapy (combination, step-down, salvage)](https://reader033.vdocuments.us/reader033/viewer/2022041609/6252f17f1b829c568d444145/html5/thumbnails/23.jpg)
Mucormycosis
Salvage therapy Step-down therapy Combination therapy Initial therapy
-Posaconazole
-Isavuconazole
-Isavuconazole
-Posaconazole
-Amphotericin B
+Posaconazole
-Amphotericin B
+Posaconazole
-Amphotericin B
After improvement in the clinical
conditions then for
several weeks
Induction therapy
minimum for 4 weeks
Duration